Skip to content
  • Monday, 26 October 2026
  • 2:19 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
Pharmaceutical R&D

ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer

Teuku Ryan Oct 26, 2026 0

The modern therapeutic landscape for advanced ovarian cancer is undergoing a profound structural evolution, driven largely by the clinical maturation…

Read More
Drexel University Researchers Engineer High-Performance One-Dimensional MXene Nanoscrolls to Revolutionize Energy Storage and Quantum ElectronicsAbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.Caltech Researchers Unlock Sub-Picosecond Optical Switching with Breakthrough Metasurface TechnologyGilead Sciences Secures Global Rights to PepStar’s Oral IL-23 Receptor Inhibitor HCXT-2001 in Landmark $1.275bn Agreement
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule IThe decline in United States drug overdose deaths is not driven by increased naloxone use according to new researchESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancerThe Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Lana Keisha Oct 26, 2026
Environmental & Analytical Chemistry
The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research
Abdurrohim Arsyad Oct 26, 2026
Pharmaceutical R&D
ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
Teuku Ryan Oct 26, 2026
Molecular & Cell Biology
The Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
Angie Faith Oct 26, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ